Specialist in domestic and international transactions and in corporate and commercial contracts.

Elena Cuatrecasas advises on M&As, joint ventures, risk capital transactions, leveraged buyouts (LBOs), management buyouts (MBOs) and buyins (MBIs) and corporate group restructuring.

She is an expert in the pharmaceutical, biotechnology, life science and TMT sectors, advising these industries and investors from a transactional and contractual perspective.

She has worked in the United Kingdom and was managing partner of the Cuatrecasas New York office from 2014 to 2017. She is an active member of the American Bar Association and the International Bar Association (IBA), regularly participating as moderator and speaker, and a member of the Spain-US Chamber of Commerce. She is also secretary of the board of directors of several international companies and author of many articles published in specialized journals and collective publications.

Training

  • Master of Laws
    University of London, 1994

    Bachelor of Laws
    Universitat de Barcelona, 1993

Mentions

Recommended lawyer
Best Lawyers, IFLR and Chambers Europe in Corporate and M&A, Private Equity, Health Care and Biotechnology

Lawyer of the Year
Best Lawyers (category: Health Care), 2012 and 2019

Publications